Suppression of hepatitis B virus-derived human hepatocellular carcinoma by NF-κB-inducing kinase-specific siRNA using liver-targeting liposomes

Hyun Ah Cho, In Sung Park, Tae Woo Kim, Yu Kyoung Oh, Ki Sook Yang, Jin Seok Kim

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Hepatitis B virus triggers an increase of NF-κB inducing kinase (NIK)-dependent NF-κB activation, followed by the promotion of hepatocellular carcinoma (HCC). Here, we examined the inhibitory effect of NIK-specific siRNA on NF-κB signaling and HCC. The results of this study indicated that these siRNAs suppressed HBV-derived HCC by regulating NIK activation. To exert a protective effect from degradation enzyme, cationic liposomes were contrived and modified to contain β-sitosterol glucoside to target the asialoglycoprotein receptors in liver cancer cells. The cationic dimyristoyl diacyltrimethylammonium propane liposomes were prepared by a reverse-phase evaporation method with slight modification. β-Sitosterol glucoside was added to the lipid mixture at the beginning of the liposome preparation for the purpose of liver targeting. These liposomes assisted the delivery of the siRNA to specific cells and protected it from various lyases, followed by the ultimate suppression of HCC.

Original languageEnglish
Pages (from-to)1077-1086
Number of pages10
JournalArchives of Pharmacal Research
Volume32
Issue number7
DOIs
Publication statusPublished - 2009 Jul 1

Fingerprint

Viruses
Hepatitis B virus
Liposomes
Liver
Small Interfering RNA
Hepatocellular Carcinoma
Phosphotransferases
Glucosides
Chemical activation
Asialoglycoprotein Receptor
Propane
Lyases
Liver Neoplasms
Evaporation
Cells
Lipids
Degradation
Enzymes
gamma-sitosterol

Keywords

  • Beta-sitosterol glucoside
  • DMTAP
  • Hepatitis B Virus
  • Liposomes
  • NF-κB-inducing kinase
  • SiRNA

ASJC Scopus subject areas

  • Drug Discovery
  • Molecular Medicine
  • Organic Chemistry

Cite this

Suppression of hepatitis B virus-derived human hepatocellular carcinoma by NF-κB-inducing kinase-specific siRNA using liver-targeting liposomes. / Cho, Hyun Ah; Park, In Sung; Kim, Tae Woo; Oh, Yu Kyoung; Yang, Ki Sook; Kim, Jin Seok.

In: Archives of Pharmacal Research, Vol. 32, No. 7, 01.07.2009, p. 1077-1086.

Research output: Contribution to journalArticle

@article{fba64ff2a7e6453c915ca30947612160,
title = "Suppression of hepatitis B virus-derived human hepatocellular carcinoma by NF-κB-inducing kinase-specific siRNA using liver-targeting liposomes",
abstract = "Hepatitis B virus triggers an increase of NF-κB inducing kinase (NIK)-dependent NF-κB activation, followed by the promotion of hepatocellular carcinoma (HCC). Here, we examined the inhibitory effect of NIK-specific siRNA on NF-κB signaling and HCC. The results of this study indicated that these siRNAs suppressed HBV-derived HCC by regulating NIK activation. To exert a protective effect from degradation enzyme, cationic liposomes were contrived and modified to contain β-sitosterol glucoside to target the asialoglycoprotein receptors in liver cancer cells. The cationic dimyristoyl diacyltrimethylammonium propane liposomes were prepared by a reverse-phase evaporation method with slight modification. β-Sitosterol glucoside was added to the lipid mixture at the beginning of the liposome preparation for the purpose of liver targeting. These liposomes assisted the delivery of the siRNA to specific cells and protected it from various lyases, followed by the ultimate suppression of HCC.",
keywords = "Beta-sitosterol glucoside, DMTAP, Hepatitis B Virus, Liposomes, NF-κB-inducing kinase, SiRNA",
author = "Cho, {Hyun Ah} and Park, {In Sung} and Kim, {Tae Woo} and Oh, {Yu Kyoung} and Yang, {Ki Sook} and Kim, {Jin Seok}",
year = "2009",
month = "7",
day = "1",
doi = "10.1007/s12272-009-1714-z",
language = "English",
volume = "32",
pages = "1077--1086",
journal = "Archives of Pharmacal Research",
issn = "0253-6269",
publisher = "Pharmaceutical Society of Korea",
number = "7",

}

TY - JOUR

T1 - Suppression of hepatitis B virus-derived human hepatocellular carcinoma by NF-κB-inducing kinase-specific siRNA using liver-targeting liposomes

AU - Cho, Hyun Ah

AU - Park, In Sung

AU - Kim, Tae Woo

AU - Oh, Yu Kyoung

AU - Yang, Ki Sook

AU - Kim, Jin Seok

PY - 2009/7/1

Y1 - 2009/7/1

N2 - Hepatitis B virus triggers an increase of NF-κB inducing kinase (NIK)-dependent NF-κB activation, followed by the promotion of hepatocellular carcinoma (HCC). Here, we examined the inhibitory effect of NIK-specific siRNA on NF-κB signaling and HCC. The results of this study indicated that these siRNAs suppressed HBV-derived HCC by regulating NIK activation. To exert a protective effect from degradation enzyme, cationic liposomes were contrived and modified to contain β-sitosterol glucoside to target the asialoglycoprotein receptors in liver cancer cells. The cationic dimyristoyl diacyltrimethylammonium propane liposomes were prepared by a reverse-phase evaporation method with slight modification. β-Sitosterol glucoside was added to the lipid mixture at the beginning of the liposome preparation for the purpose of liver targeting. These liposomes assisted the delivery of the siRNA to specific cells and protected it from various lyases, followed by the ultimate suppression of HCC.

AB - Hepatitis B virus triggers an increase of NF-κB inducing kinase (NIK)-dependent NF-κB activation, followed by the promotion of hepatocellular carcinoma (HCC). Here, we examined the inhibitory effect of NIK-specific siRNA on NF-κB signaling and HCC. The results of this study indicated that these siRNAs suppressed HBV-derived HCC by regulating NIK activation. To exert a protective effect from degradation enzyme, cationic liposomes were contrived and modified to contain β-sitosterol glucoside to target the asialoglycoprotein receptors in liver cancer cells. The cationic dimyristoyl diacyltrimethylammonium propane liposomes were prepared by a reverse-phase evaporation method with slight modification. β-Sitosterol glucoside was added to the lipid mixture at the beginning of the liposome preparation for the purpose of liver targeting. These liposomes assisted the delivery of the siRNA to specific cells and protected it from various lyases, followed by the ultimate suppression of HCC.

KW - Beta-sitosterol glucoside

KW - DMTAP

KW - Hepatitis B Virus

KW - Liposomes

KW - NF-κB-inducing kinase

KW - SiRNA

UR - http://www.scopus.com/inward/record.url?scp=68649120934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68649120934&partnerID=8YFLogxK

U2 - 10.1007/s12272-009-1714-z

DO - 10.1007/s12272-009-1714-z

M3 - Article

VL - 32

SP - 1077

EP - 1086

JO - Archives of Pharmacal Research

JF - Archives of Pharmacal Research

SN - 0253-6269

IS - 7

ER -